GlassScriptPhysician profile
Jeffrey M Ferber
NPI 1609890813
$9,153.24
in general payments reported to CMS, 2019-2025
55 companies · $1,824 in 2025
The $1,824 reported for 2025 was more than what 94% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,509 · 2020: $494 · 2021: $1,041 · 2022: $1,770 · 2023: $1,247 · 2024: $1,268 · 2025: $1,824.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,339.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,338.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,040.42 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Abbvie INC. | $1,018.14 | 2021-2025 | |
| Lilly USA, LLC | $686.32 | 2021-2025 | Zepbound, Mounjaro, Jardiance |
| Novo Nordisk INC | $630.48 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Amgen INC. | $618.68 | 2019-2025 | Evenity, Prolia, Repatha |
| Pfizer INC. | $455.52 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $442.85 | 2019-2025 | Spravato, Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $389.61 | 2022-2025 | |
| Boston Scientific Corporation | $358.06 | 2019-2025 | Wavewriter Alpha Prime 16, Watchman Flx |
| Novartis Pharmaceuticals Corporation | $268.46 | 2019-2023 | |
| Glaxosmithkline, LLC. | $202.73 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Abiomed | $190.75 | 2024-2025 | Impella |
| Merck Sharp & Dohme LLC | $182.23 | 2019-2025 | Dificid, Gardasil 9, Capvaxive |
| Astellas Pharma US INC | $170.31 | 2019-2024 | Veozah |
| Seqirus USA INC | $152.53 | 2022-2025 | Fluad, Flucelvax, Fluad Quadrivalent |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $146.49 | 2023-2025 | Rexulti |
| Exact Sciences Corporation | $137.16 | 2023-2025 | Cologuard Collection Kit |
| Biogen, INC. | $131.50 | 2021-2022 | |
| Nevro Corp. | $128.09 | 2022-2023 | Senza |
| Amarin Pharma, INC. | $124.77 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $122.27 | 2023-2025 | Austedo Xr, Austedo Xr, Austedo |
| Sanofi-Aventis U.S. LLC | $121.94 | 2019-2022 | |
| Sanofi Pasteur INC. | $112.22 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $99.68 | 2021-2024 | Tradjenta, Jardiance |
| Mannkind Corporation | $96.20 | 2019-2022 | |
| Si-Bone, INC. | $84.22 | 2021-2025 | |
| Tactile Systems Technology INC | $72.73 | 2022-2025 | Nimbl, Flexitouch Plus |
| Avanir Pharmaceuticals, INC. | $69.99 | 2019 | |
| Eisai INC. | $65.52 | 2021-2022 | |
| Abbott Laboratories | $64.69 | 2022-2023 | Octrode, Mitraclip |
| Intuitive Surgical, INC. | $61.97 | 2024 | |
| Electromed, INC. | $55.76 | 2022-2023 | Smartvest |
| Linus Health, INC. | $55.43 | 2022 | |
| Edwards Lifesciences Corporation | $50.80 | 2024-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Lundbeck LLC | $50.15 | 2025 | Rexulti |
| E.R. Squibb & Sons, L.L.C. | $47.77 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $45.25 | 2022 | |
| Zyla Life Sciences, INC. | $37.81 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $36.91 | 2019 | |
| Philips North America LLC | $34.82 | 2023-2024 | (Ck7) Extended Holter |
| Ucb, INC. | $30.71 | 2021 | |
| Teleflex LLC | $24.94 | 2021 | |
| Radius Health, INC. | $24.76 | 2024 | Tymlos |
| Alk-Abello, INC | $24.05 | 2024 | Grastek, Ragwitek, Odactra |
| Cmp Pharma, INC. | $23.85 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.18 | 2023 | Lifevest |
| Axsome Therapeutics, INC. | $20.09 | 2023 | Auvelity |
| Sun Pharmaceutical Industries INC. | $19.92 | 2022 | |
| Corcept Therapeutics | $18.28 | 2025 | Korlym |
| Esperion Therapeutics, INC. | $16.60 | 2024 | Nexletol |
| Topcon Healthcare Solutions, INC. | $14.99 | 2020 | |
| Scilex Pharmaceuticals INC. | $14.77 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $14.50 | 2025 | Zoryve |
| Mckesson Medical-Surgical, INC. | $12.77 | 2019 | |
| Dexcom, INC. | $11.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Ferber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.